EP300 and lymphoma: While poor evidence of these mechanisms is currently available for lymphoma, initial studies in hepatocellular carcinoma suggest that p300/CBP epigenetically induces expression of glycolysis-related enzymes (Cai et al., 2021), which may sustain HAT activity through increased acetyl-CoA levels.